A detailed history of Meeder Asset Management Inc transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Meeder Asset Management Inc holds 267 shares of FLGT stock, worth $5,374. This represents 0.0% of its overall portfolio holdings.

Number of Shares
267
Previous 1,658 83.9%
Holding current value
$5,374
Previous $32,000 84.38%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$19.6 - $25.06 $27,263 - $34,858
-1,391 Reduced 83.9%
267 $5,000
Q1 2024

May 07, 2024

BUY
$21.55 - $29.29 $35,729 - $48,562
1,658 New
1,658 $35,000
Q1 2023

May 15, 2023

SELL
$29.39 - $36.27 $181,042 - $223,423
-6,160 Reduced 15.84%
32,726 $1.02 Million
Q4 2022

Feb 14, 2023

SELL
$29.23 - $40.28 $133,814 - $184,401
-4,578 Reduced 10.53%
38,886 $1.16 Million
Q3 2022

Nov 14, 2022

BUY
$37.92 - $63.74 $422,732 - $710,573
11,148 Added 34.5%
43,464 $1.66 Million
Q2 2022

Aug 08, 2022

BUY
$47.98 - $62.75 $296,708 - $388,046
6,184 Added 23.66%
32,316 $1.76 Million
Q1 2022

May 10, 2022

BUY
$49.85 - $96.11 $1.3 Million - $2.51 Million
26,132 New
26,132 $1.63 Million
Q4 2021

Feb 11, 2022

SELL
$77.3 - $105.0 $6,106 - $8,295
-79 Closed
0 $0
Q3 2021

Nov 08, 2021

SELL
$74.87 - $110.87 $6,438 - $9,534
-86 Reduced 52.12%
79 $7,000
Q2 2021

Aug 09, 2021

SELL
$66.8 - $100.45 $19,104 - $28,728
-286 Reduced 63.41%
165 $15,000
Q1 2021

Apr 28, 2021

BUY
$59.3 - $183.85 $25,676 - $79,607
433 Added 2405.56%
451 $44,000
Q4 2020

Feb 09, 2021

SELL
$31.01 - $52.1 $31,165 - $52,360
-1,005 Reduced 98.24%
18 $1,000
Q3 2020

Nov 02, 2020

BUY
$15.89 - $50.51 $16,255 - $51,671
1,023 New
1,023 $41,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $609M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.